Six regulations into one: what the IRDAI (Insurance Products) Regulations 2024 mean for product design and policyholders

On 22 March 2024, the Gazette of India (Extraordinary, Part III, Section 4, No. 206) carried a notification that quietly rewrote the rulebook for every life, general and health insurance product sold in the country. The Insurance Regulatory and Development Authority of India (Insurance Products) Regulations, 2024 collapsed six separate regulations into a single principle-based framework, and they came into force on 1 April 2024. For policyholders, the headline is simple: the rules that decide how a product is designed, priced and what you get back if you walk away early now sit in one document, signed by IRDAI Chairperson Debasish Panda.

This deep dive explains what the 2024 regulation actually says, why the consolidation matters for the cover you already hold, and the specific numbers that govern surrender value, paid-up cover, pre-existing-disease waiting periods and the 60-month moratorium. Every figure below is drawn from the gazetted text itself.

The Rule / Product

The regulation was notified at Hyderabad on 20 March 2024 under File No. IRDAI/Reg/8/202/2024, exercising powers under Section 114A of the Insurance Act, 1938 and Sections 14 and 26 of the IRDA Act, 1999 (the full gazetted text is published on irdai.gov.in). Regulation 1 states the rules apply to every insurer holding a certificate of registration to transact life, general or health insurance business in India, and Regulation 1(4) commits the Authority to review the framework once every three years unless an earlier review is warranted.

The core move is consolidation. Six earlier regulations, the oldest dating to 2015, were repealed under Regulation 9 from the date the new rules came into force, as recorded in the IRDAI consolidated regulations register. The table below maps what was merged into the single 2024 instrument.

Regulation 2 sets out three objectives: helping insurers respond faster to evolving market needs and design innovative products, protecting policyholders' interests through good governance in design and pricing, and ensuring robust oversight of every product including innovative ones. Regulation 4 then lists the design principles every insurer must follow, including that a product must cover an insurable risk with a genuine underlying risk transfer and must be "simple to understand and not complex".

Governance is handed to a Board-constituted Product Management Committee (PMC). Under Regulation 6, the PMC must verify regulatory compliance, recommend products for filing under the "File and Use" route (where a Unique Identification Number is allotted before marketing) or launch them under "Use and File", and the Appointed Actuary must review every product offered for sale at least once a year. Life products follow Schedule I and III, general products Schedule II and III, and health products Schedule III.

Why It Matters

Consolidation is not cosmetic. Before 1 April 2024 a policyholder querying a surrender value, an agent pricing a ULIP and an actuary signing off a health plan were reading three different rulebooks written across nine years. The single 2024 framework means the surrender-value maths, the paid-up-value formula and the disclosure norms now cross-reference each other inside one document, which reduces the wording gaps insurers historically exploited.

The bigger consumer win sits in Schedule I. The regulation guarantees that a non-linked policy surrendered after just two years' premiums have been paid carries a guaranteed surrender value, and crucially that the amount payable is the higher of the guaranteed surrender value or the special surrender value. For decades, policyholders exiting traditional plans were routinely paid the lower guaranteed figure; the 2024 text closes that gap. If you are comparing a traditional savings plan against a fund, our endowment vs mutual fund calculator and the ULIP vs mutual fund tool let you test how surrender mechanics affect real returns.

On the health side, Schedule III caps the pre-existing-disease waiting period at a maximum of 36 months of continuous coverage and fixes a 60-month moratorium after which no claim can be contested except on grounds of established fraud. These are hard ceilings that no policy wording can extend, which directly shapes how soon a claim becomes uncontestable. This regulation is also the parent under which IRDAI's 2024 health master circular operationalised faster cashless turnaround, covered in our report on the 1-hour cashless approval and 3-hour discharge norms.

Worked Numbers

Consider a non-linked endowment policy with a level annual premium of Rs 1,00,000 over a 20-year term, with no survival benefits paid out along the way. Under Schedule I, Clause 4(A)(a), the guaranteed surrender value is a fixed percentage of total premiums paid, less any survival benefits. The slab structure works as follows.

The 90% floor in the final years must follow a smooth progression and converge to at least 90% of total premiums paid as the policy approaches maturity. For single-premium products the floors are more generous: 75% of the premium if surrendered any time within the third policy year, rising to 90% in the fourth year. Remember that the insurer must pay the higher of this guaranteed figure or the special surrender value, which on a participating policy reflects the asset share built up.

Paid-up cover follows a separate formula. Under Clause 4(A)(a)(7), if you stop paying premiums after a policy has acquired value, the paid-up sum assured equals the ratio of premiums actually paid to total premiums originally payable, multiplied by the sum assured. On our 20-year example, stopping after 8 years gives a paid-up death cover of 8/20, or 40%, of the original sum assured. The policy does not lapse; it stays in force at the reduced figure, unless the paid-up sum assured falls below Rs 2,500 (or Rs 500 for micro-insurance), in which case the insurer may terminate it after the revival period by paying the surrender value.

For unit-linked policies, Schedule I, Clause 4(B) requires that on surrender the value is at least equal to the unit fund value, and group fund-based products may levy a surrender charge of no more than 0.05% of the total fund value, capped at Rs 5,00,000, if surrendered within the third annual renewal. To size the protection cover you actually need before buying any of these, the term insurance premium calculator and human life value approach give a defensible starting figure.

Pitfalls

The 2024 regulation tightens design rules, but it does not abolish the policy-wording traps that decide whether a claim is paid in full. These are the clauses to read before you sign.

First, the pre-existing-disease definition. Under Schedule III, Clause 1.6, a PED is any condition diagnosed, or for which advice or treatment was received, within 36 months before the policy commenced. The maximum waiting period is also 36 months of continuous coverage, but insurers are free to offer shorter periods, so two policies with identical premiums can have very different waiting clocks. The PED definition does not apply to overseas travel policies.

Second, specific waiting periods. Clause 1.7 allows a separate waiting period of up to 36 months for named diseases or treatments, except those arising from an accident. A policy may pass the PED test yet still defer a planned procedure under this clause, so check both lists.

Third, sub-limits, co-pay and room-rent caps. The regulation governs product design, not every commercial sub-limit an insurer prices in. A sub-limit on a specific procedure, a co-payment percentage you must bear on every claim, or a room-rent capping clause can still shrink a settlement sharply, because room category often drives proportionate deductions on the entire bill. Model the impact with our room rent impact calculator before assuming your sum insured is fully usable.

Fourth, the moratorium clock resets on top-ups. Clause 8 of Schedule III makes a policy uncontestable after 60 continuous months, but where the sum insured is later enhanced, the 60-month count for the enhanced limit starts only from the date of that enhancement. A long-held policy with a recent sum-insured increase therefore has two different moratorium clocks running.

Fifth, the grace-period is short. For both life and health policies the grace period is 15 days where premium is paid monthly and 30 days in all other cases. Miss it and a life policy can lapse or fall to paid-up status, while a health policy can lose continuity benefits on waiting periods unless renewed within the condonable grace window. IRDAI's parallel enforcement teeth, including the Rs 5,000-per-day penalty on insurers who delay Ombudsman awards, are covered in our explainer on the 2024 Policyholders Protection master circular.

FAQ

When did the IRDAI (Insurance Products) Regulations, 2024 come into force?

The regulations were notified on 20 March 2024 and published in the Gazette of India on 22 March 2024. Under Regulation 1(2) they came into force from the date of publication or 1 April 2024, whichever is later, so the operative date is 1 April 2024.

Which six regulations did the 2024 framework replace?

Regulation 9 repealed the IRDAI (Micro Insurance) Regulations 2015, the (Minimum Limits for Annuities and other benefits) Regulations 2015, the (Acquisition of Surrender and Paid up values) Regulations 2015, the (Health Insurance) Regulations 2016, the (Unit Linked Insurance Products) Regulations 2019 and the (Non-Linked Insurance Products) Regulations 2019.

What is the minimum surrender value on a traditional life policy?

For non-single-premium non-linked policies, the guaranteed surrender value is 30% of total premiums paid if you surrender in the second year, 35% in the third year, 50% between the fourth and seventh year, and at least 90% in the final two years. The insurer must pay the higher of this guaranteed value or the special surrender value.

How long is the pre-existing-disease waiting period under the 2024 rules?

Schedule III caps the PED waiting period at a maximum of 36 months of continuous coverage. The definition itself covers conditions diagnosed or treated within 36 months before the policy started, and insurers may voluntarily offer shorter waiting periods.

What does the 60-month moratorium actually protect?

After 60 continuous months of coverage, including periods carried over through portability or migration, an insurer cannot contest a policy or claim on grounds of non-disclosure or misrepresentation, except where established fraud is proved. For any later increase in sum insured, the 60-month clock for the enhanced portion restarts from the enhancement date.

Can a health insurer refuse to renew my policy after a claim?

No. Under Clause 9 of Schedule III, a health policy must be renewable except on grounds of established fraud, non-disclosure or misrepresentation, and an insurer cannot deny renewal merely because you made claims in earlier years, other than benefit-based policies such as critical-illness cover that terminate on payout.

How often will IRDAI review this regulation?

Regulation 1(4) requires the Authority to review the framework once every three years from the date of publication, unless an earlier review, repeal or amendment is warranted. The first scheduled review therefore falls due by 2027.